The J Code: J2182 is aligned to the drug NUCALA. Nucala is a maintenance treatment for patients with certain types of severe asthma.
Duration of therapy: J-Code: ICD10: Is this a new start or continuation of therapy? If your patient has already begun treatment with drug samples of Cinqair or Nucala, please choose new start of therapy. new start continued therapy
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care. If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
Revenue code 905 or 912, CPT code , S9480, HCPCS code H2024 J2182 mepolizumab (Nucala). J2323 natalilzumab (Tysabri). J2326
Nucala (mepolizumab subcutaneous injection – GlaxoSmithKline) HCPCS. Codes. Description. J2182. Injection, mepolizumab, 1 mg. References. 1
J . CPT CODE: J. $7.62. J Q. CPT CODE: J. $5.03. J . CPT CODE: J. $5.03 CODE: $2,300.78. S . CPT CODE: $697.04. S .
The member will need to fill the self-administered version under the pharmacy benefit. Drug Name. J-Code Nucala. J2182. Obizur. J7188.
Nucala (mepolizumab) is NOT being prescribed as: (a) CODE. DESCRIPTION. J2182. Injection Steinfeld J, Bradford ES, Brown J, et al.
The J Code: J2182 is aligned to the drug NUCALA. Nucala is a maintenance treatment for patients with certain types of severe asthma. Nucala has been shown to help reduce symptoms in patients with a type of asthma called eosinophilic asthma.
R.